date:Mar 04, 2019
s particularly important for patients on immunotherapy, because our microbiome plays a major role in activating our body's immune response. In particular, bacteria in the Ruminococcaceae family have been shown to improve responses to PD-1 blockade immunotherapy, but researchers don't know why some people naturally have more of this bacteria than others. The best way we know of, so far, to improve our chances of having these helpful bugs in our system is to increase microbiome diversity on the wh